Journal of thrombosis and haemostasis : JTH
Journal
Overview
publication venue for
-
Macrothrombosis and stroke in patients with mild Covid-19 infection.
2020
-
Accuracy and interrater agreement of death event adjudications by physician trainees: Validation of the ISTH definition of pulmonary embolism-related death in an autopsy cohort.
2023
-
Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin: insights from the Highlow study..
21.
2022
-
Ischemic Stroke with Cancer: Hematologic and Embolic Biomarkers and Clinical Outcomes.
2022
-
Diagnosis and management of severe congenital protein C deficiency (SCPCD): Communication from the SSC of the ISTH.
2022
-
ISTH definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: Validation in an autopsy cohort..
19.
2021
-
Tissue factor upregulation is associated with SARS-CoV-2 in the lungs of COVID-19 patients..
19.
2021
-
Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation..
18.
2020
-
Extreme thrombocytosis is associated with critical illness and young age, but not increased thrombotic risk, in hospitalized pediatric patients..
18.
2020
-
Use of plasma-derived factor X concentrate in neonates and infants with congenital factor X deficiency..
18.
2020
-
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository..
17.
2019
-
Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSC..
17.
2019
-
The risk of major bleeding in patients with suspected heparin-induced thrombocytopenia..
17.
2019
-
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome.
2018
-
Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis..
15.
2017
-
Reduction of annexin A5 anticoagulant ratio identifies antiphospholipid antibody-positive patients with adverse clinical outcomes..
15.
2017
-
Associations of coagulation factors IX and XI levels with incident coronary heart disease and ischemic stroke: the REGARDS study..
15.
2017
-
Hemostasis biomarkers and risk of sepsis: the REGARDS cohort..
14.
2016
-
Clinical adherence to thrombophilia screening guidelines at a major tertiary care hospital..
14.
2016
-
Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity..
13.
2015
-
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings..
13.
2015
-
Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis..
13.
2015
-
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia..
13.
2015
-
Stalled cerebral capillary blood flow in mouse models of essential thrombocythemia and polycythemia vera revealed by in vivo two-photon imaging..
12.
2014
-
Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa..
12.
2014
-
Decreased plasma cytokines are associated with low platelet counts in aplastic anemia and immune thrombocytopenic purpura..
10.
2012
-
Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia..
9.
2011
-
Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation..
9.
2011
-
The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion..
8.
2010
-
Risk factors for developing a new venous thromboembolism in ambulatory patients with non-hematologic malignancies and impact on survival for gastroesophageal malignancies..
8.
2010
-
Pharmacokinetics and safety of fibrinogen concentrate..
7.
2009
-
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study..
7.
2009
-
Endogenous activated protein C signaling is critical to protection of mice from lipopolysaccaride-induced septic shock..
7.
2009
-
Power Doppler sonography in the diagnosis of hemophilic synovitis--a promising tool..
6.
2008
-
Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions..
6.
2008
-
A randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitor..
6.
2008
-
Persistent platelet activation in patients with type 2 diabetes treated with low doses of aspirin..
5.
2007
-
Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin..
5.
2007
-
Initial experience with factor-Xa inhibition in percutaneous coronary intervention: the XaNADU-PCI Pilot..
2.
2004
-
Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias..
2.
2004
-
Platelet FcgammaRIIA His131Arg polymorphism and platelet function: antibodies to platelet-bound fibrinogen induce platelet activation..
1.
2003
-
The international immune tolerance study: a multicenter prospective randomized trial in progress..
4.
2006
-
Resistance to annexin A5 binding and anticoagulant activity in plasmas from patients with the antiphospholipid syndrome but not with syphilis..
4.
2006
-
Venous thromboembolism prophylaxis: do trial results enable clinicians and patients to evaluate whether the benefits justify the risk? Proceedings of an Ad Hoc Working Group Meeting.
2013
-
False-positive tests for heparin-induced thrombocytopenia in patients with antiphospholipid syndrome and systemic lupus erythematosus: a rebuttal.
2010
-
Adverse effects of estrogen therapy in a subset of women with ITP.
2004
-
Megakaryocytes, malignancy and bone marrow vascular niches.
2012
-
Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia.
2009
-
Immune tolerance therapy for factor VIII inhibitors: moving from empiricism to an evidence-based approach.
2007
-
Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1).
2003
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)